Skip to main content
Mark Davis, MD, Pathology, Worcester, MA

Mark B Davis MD

Hematopathology, Anatomic Pathology, Clinical Pathology


Associate Professor, Medicine, Brigham & Women's Hospital, Harvard Medical

Join to View Full Profile
  • 1 Innovation DrSte 3Worcester, MA 01605

  • Phone+1 508-793-6290

  • Fax+1 913-588-7073

Are you Dr. Davis?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Mark Davis, MD is a board certified pathologist in Worcester, Massachusetts. He is currently licensed to practice medicine in Massachusetts and Washington. He is an Associate Professor at Brigham & Women's Hospital.

Education & Training

  • UMass Chan Medical School
    UMass Chan Medical SchoolFellowship, Hematopathology, 2011 - 2012
  • University of Kansas School of Medicine
    University of Kansas School of MedicineResidency, Pathology-Anatomic and Clinical, 2007 - 2011
  • Ross University School of Medicine
    Ross University School of MedicineClass of 2007

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2012 - 2026
  • WA State Medical License
    WA State Medical License 2022 - 2025
  • Pathology - Anatomic/Pathology - Clinical
    American Board of Pathology Pathology - Anatomic/Pathology - Clinical
  • Pathology - Hematology
    American Board of Pathology Pathology - Hematology

Press Mentions

  • Embracing the Transformative Power of Digital Pathology
    Embracing the Transformative Power of Digital PathologyAugust 4th, 2021
  • Breakthrough in MS Sheds Light on All Autoimmune Disease, Including Lupus
    Breakthrough in MS Sheds Light on All Autoimmune Disease, Including LupusAugust 27th, 2019
  • Blood Proteins Linked to Severity of Chronic Fatigue Syndrome
    Blood Proteins Linked to Severity of Chronic Fatigue SyndromeJuly 31st, 2017